Mark Tye
Scientist, Revolution Medicines
Enrollment Year - 2016
Mazitschek Lab, MGH
Mark Tye(he/him/his)
Advisor(s): Ralph Mazitschek
Thesis: An integrated chemogenomic approach exploring and exploiting prolyl-tRNA synthetase as target for next-generation malaria and cancer therapies
Alma Mater: University of California - Berkeley